Scott Eugene Conner,Philip Arthur Hipskind,Jianke Li,Guoxin Zhu
申请号：
US12093601
公开号：
US08691856B2
申请日:
2006.11.16
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention discloses novel compounds of Formula (I), or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.
